"Our top-rated podiatrist in Belleville, IL, at Podiatry 1st offers the leading treatments for podiatry treatment using the most advanced technology. Our experienced podiatrist in Belleville, IL has transformed over 10,000 lives with our diabetic foot care, laser pain therapy, treatment for heel pain & more. Although we are a podiatrist in Belleville, IL, we also service the surrounding cities including Columbia, Fairview Heights, O'Fallon, Smithton, Okawville, Mascoutah, Freeburg & Trenton, IL. Our podiatrist provide experienced care with a consultative approach. For 5-star-rated treatment from our leading podiatrist in Belleville, IL, choose Podiatry 1st!"

During the past decade, Podiatry 1st conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Podiatry 1st" #1 sponsor was "Celularity Incorporated" with 1 trials, followed by "Genentech, Inc." with 1 trials sponsored, "Ilkos Therapeutic Inc." with 1 trials sponsored, "Integra LifeSciences Corporation" with 1 trials sponsored and "Ipsen" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

According to Clinical.Site data, the most researched conditions in "Podiatry 1st" are "Diabetic Foot" (1 trials), "Diabetic Foot Ulcer" (1 trials), "Hallux Abducto Valgus" (1 trials), "Neuropathic Diabetic Foot Ulcers" (1 trials) and "Peripheral Arterial Disease" (1 trials). Many other conditions were trialed in "Podiatry 1st" in a lesser frequency.

Most popular intervention types in "Podiatry 1st" are "Biological" (3 trials), "Drug" (3 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "10 x 10^6 cells" (1 trials), "3 x 10^6 cells" (1 trials), "30 x 10^6 cells" (1 trials) and "Botulinum toxin type A" (1 trials). Other intervention names were less common.

The vast majority of trials in "Podiatry 1st" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Podiatry 1st". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Podiatry 1st, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Podiatry 1st, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".